Cargando…

PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales: Kawaguchi, Shin-Ichiro, Sato, Kazuya, Ikeda, Takashi, Izawa, Junko, Hayakawa, Hiroko, Nagayama, Takashi, Umino, Kento, Morita, Kaoru, Tominaga, Kaoru, Endo, Hitoshi, Kanda, Yoshinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430077/
http://dx.doi.org/10.1097/01.HS9.0000973888.84145.02
_version_ 1785090867771473920
author Kawaguchi, Shin-Ichiro
Sato, Kazuya
Ikeda, Takashi
Izawa, Junko
Hayakawa, Hiroko
Nagayama, Takashi
Umino, Kento
Morita, Kaoru
Tominaga, Kaoru
Endo, Hitoshi
Kanda, Yoshinobu
author_facet Kawaguchi, Shin-Ichiro
Sato, Kazuya
Ikeda, Takashi
Izawa, Junko
Hayakawa, Hiroko
Nagayama, Takashi
Umino, Kento
Morita, Kaoru
Tominaga, Kaoru
Endo, Hitoshi
Kanda, Yoshinobu
author_sort Kawaguchi, Shin-Ichiro
collection PubMed
description
format Online
Article
Text
id pubmed-10430077
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104300772023-08-17 PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA Kawaguchi, Shin-Ichiro Sato, Kazuya Ikeda, Takashi Izawa, Junko Hayakawa, Hiroko Nagayama, Takashi Umino, Kento Morita, Kaoru Tominaga, Kaoru Endo, Hitoshi Kanda, Yoshinobu Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430077/ http://dx.doi.org/10.1097/01.HS9.0000973888.84145.02 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Kawaguchi, Shin-Ichiro
Sato, Kazuya
Ikeda, Takashi
Izawa, Junko
Hayakawa, Hiroko
Nagayama, Takashi
Umino, Kento
Morita, Kaoru
Tominaga, Kaoru
Endo, Hitoshi
Kanda, Yoshinobu
PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title_full PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title_fullStr PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title_full_unstemmed PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title_short PB1757: NOVEL THERAPEUTIC STRATEGY TARGETING CELLULAR REDOX SYSTEMS USING DIMETHYL FUMARATE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
title_sort pb1757: novel therapeutic strategy targeting cellular redox systems using dimethyl fumarate and venetoclax in acute myeloid leukemia
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430077/
http://dx.doi.org/10.1097/01.HS9.0000973888.84145.02
work_keys_str_mv AT kawaguchishinichiro pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT satokazuya pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT ikedatakashi pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT izawajunko pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT hayakawahiroko pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT nagayamatakashi pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT uminokento pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT moritakaoru pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT tominagakaoru pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT endohitoshi pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia
AT kandayoshinobu pb1757noveltherapeuticstrategytargetingcellularredoxsystemsusingdimethylfumarateandvenetoclaxinacutemyeloidleukemia